| 摘要 |
<p>The present invention is directed to the TVEMF-expansion of mammalian blood stem cells, preferably CD34+/CD38- cells, to compositions resulting from the TVEMF-expanded cells, and to a method of treating heart disease or repairing heart tissue with the compositions.</p> |
